Findings reveal AFib patients are fearful of complications from the condition, but not all are treating their AFib quicky after diagnosis
September 14, 2022
Biosense Webster AFib Survey Findings Reveal Surprising Patient Behaviors and At-Risk Population Awareness Gaps
September 14, 2022 — In recognition of Atrial Fibrillation (AFib) Awareness Month, Biosense Webster, Inc., part of…
Read More
Anthos Therapeutics has announced that Abelacimab has received FDA Fast Track Designation for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
September 13, 2022
Anthos Therapeutics Announces Abelacimab Received FDA Fast Track Designation for the Prevention of Stroke and Systemic Embolism in Patients with AFib
September 13, 2022 — Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for…
Read More
Image showing a co-registration of invasive coronary angiography (A), coronary CTA and straight MPR (panel B and C) with CTA cross sections (panel D), corresponding OCT cross sections and longitudinal OCT view (E).
September 13, 2022
CCTA Effective in Pre-procedural Planning of Myocardial Revascularization Interventions
September 13, 2022 — The latest expert consensus document from the Society of Cardiovascular Computed Tomography (SCCT…
Read More
The ĹŚNĹŚ endovascular retrieval system was recently used to remove a malpositioned leadless pacemaker (LPM) that embolized to the right pulmonary artery in a 52- year-old patient, ĹŚNĹŚCOR LLC announced.
September 13, 2022
First-In-Human Use of the ĹŚNĹŚ Retrieval System for Percutaneous Removal of an Embolized Leadless Pacemaker from the Right Pulmonary Artery
September 13, 2022 — The ŌNŌ endovascular retrieval system was recently used to remove a malpositioned leadless…
Read More
TherOx Console
September 13, 2022
First Patient Enrolled in AMIHOT III Trial Investigating ZOLL’s Supersaturated Oxygen Therapy in Heart Attack Patients
September 13, 2022 — ZOLL Medical Corporation, an Asahi Kasei company that manufactures medical devices and related…
Read More
DAIC editors outline some highlights of what to expect from this year’s conference.
By Melinda Taschetta-Millane
September 12, 2022
Transcatheter Cardiovascular Therapeutics (TCT) 2022 Conference Preview
The Transcatheter Cardiovascular Therapeutics (TCT) conference, which is the Cardiovascular Research Foundation's (CRF…
Read More
Philips Spectral Angio CT suite
September 12, 2022
Philips Announces New Milestones in the Development of the World’s First Spectral Detector Angio CT Solution
September 12, 2022 — Royal Philips, a global leader in health technology, announced new milestones in the development…
Read More
WATCHMAN FLX now the only LAAC technology in the United States that allows for either DAPT or OAC immediately following implantation
September 12, 2022
Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option
September 12, 2022 — Boston Scientific Corporation has received U.S. Food and Drug Administration (FDA) approval to…
Read More
Computed tomography 3D surface rendering of the lungs and heart from a patient with pulmonary arterial hypertension demonstrating trachea and major airways (yellow), an enlarged heart (red), enlarged main pulmonary artery (large blue vessel on top of heart) and thinning of the peripheral pulmonary vessels (blue). Marcus Y. Chen, M.D., NHLBI
September 12, 2022
Novel Blood Test Helps Evaluate Severity in Pulmonary Arterial Hypertension, a Rare Lung Disease
September 12, 2022 — Researchers at the National Institutes of Health have found that a novel blood test can be used to…
Read More
Results from ENVISAGE-TAVI AF show mortality risk score for AFib patients undergoing TAVR. Image courtesy of Mount Sinai Health System
September 09, 2022
New Risk Score Predicts Mortality for Atrial Fibrillation Patients Undergoing Transcatheter Aortic Valve Replacement
September 9, 2 022 — A large-scale international study led by Mount Sinai has yielded the first risk score that can…
Read More
Araz Rawshani, Sahlgrenska Academy at the University of Gothenburg. Photo by Charlotta Sjöstedt
September 09, 2022
Cardiac Arrest Survival Rate Rising
September 9, 2022 — The probability of surviving sudden cardiac arrest outside hospital has more than doubled in 30…
Read More
The U.S. Food and Drug Administration (FDA) is alerting healthcare providers about potential clip lock malfunctions with MitraClip Clip Delivery Systems manufactured by Abbott.
September 09, 2022
FDA Alerts Healthcare Providers to Potential for Clip Lock Malfunctions in Abbott MitraClip Device
September 9, 2022 — The U.S. Food and Drug Administration (FDA) is alerting healthcare providers about potential clip…
Read More
investigator Michelle O’Donoghue, MD, MPH, a senior investigator of the TIMI Study Group in the Division of Cardiovascular Medicine. Image courtesy of Michelle O'Donoghue/Brigham and Women's Hospital
September 08, 2022
FOURIER-OLE Trial Finds that Long-term Use of Evolocumab Further Reduced Cardiovascular Events
September 8, 2022 — A clinical trial led by investigators from Brigham and Women’s Hospital has found that the long-…
Read More
PrepMD RMS, the premier cardiac clinical solutions company, announced today the acquisition of the intellectual property and technology assets of LindaCare, a digital health company specializing in remote monitoring.
September 08, 2022
Leading Cardiac Remote Monitoring Company Acquires Technology IP to Boost Its Robust Product Portfolio
September 8, 2022 — PrepMD RMS, the premier cardiac clinical solutions company, announced today the acquisition of the…
Read More
The OCTARAY Mapping Catheter with TRUEref Technology provides physicians with the precise information needed for catheter ablation procedures that treat cardiac arrhythmias
September 08, 2022
Biosense Webster Launches the OCTARAY Mapping Catheter with TRUErefTechnology
September 8, 2022 — Biosense Webster, Inc., part of Johnson & Johnson MedTech‡, announced the release of the…
Read More
Top 10 content for the month of August 2022
By Melinda Taschetta-Millane
September 07, 2022
Top 10: A Look at the Hot Topics from August
Here is a rundown of what you and your colleagues found to be most interesting in the fields of diagnostic and…
Read More
Volta VX1 decision support software reproduces expert-physician electrogram (EGM) analysis that can assist physicians in the real-time identification of specific abnormal electrograms in a persistent atrial fibrillation (AF) population
September 07, 2022
Volta Medical’s AI Based solution for Patients in Atrial Fibrillation Achieves Robust Validation in First Peer-Reviewed Publication
September 7, 2022 —  Nuwellis, Inc., a commercial-stage company focused on transforming the lives of people with fluid…
Read More
Graphical abstract During COVID19 total lockdown in 2020 in France, a significant reduction in vascular stiffness, recorded by home smart scales, was observed.© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society o f Cardiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any me
September 07, 2022
Strict COVID Lockdowns in France Improved Cardiovascular Health
September 7, 2022 — A new paper in European Heart Journal - Digital Health, published by Oxford University Press,…
Read More
Societies outline recommendations for hardware and software, training, competency, cross-specialty and collaboration
September 07, 2022
New ASNC-led Guideline Details How to Use CT in Hybrid Nuclear-CT Cardiac Imaging
September 7, 2022 — The American Society of Nuclear Cardiology (ASNC) and three partner societies have come together to…
Read More
Prespecified meta-analysis of DELIVER and EMPEROR-Preserved presented in a Hot Line Session at ESC Congress 2022
September 06, 2022
Meta-Analysis Strengthens Evidence for SGLT2 Inhibitors in Patients With Heart Failure
September 6, 2022 — An analysis of more than 12,000 patients has found that the SGLT2 inhibitors dapagliflozin and …
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now